Scarica l'app Stockscreener
1.29
5.31%
0.065
Dopo l'orario di chiusura:
1.27
-0.02
-1.55%
Precedente Chiudi:
$1.225
Aprire:
$1.23
Volume 24 ore:
105.08K
Relative Volume:
1.26
Capitalizzazione di mercato:
$54.10M
Reddito:
-
Utile/perdita netta:
$-14.47M
Rapporto P/E:
-1.0403
EPS:
-1.24
Flusso di cassa netto:
$-12.19M
1 W Prestazione:
-9.15%
1M Prestazione:
-28.73%
6M Prestazione:
-45.11%
1 anno Prestazione:
-56.27%
Intervallo 1D:
$1.17
$1.29
Intervallo di 1 settimana:
$1.17
$1.4594
Portata 52W:
$1.17
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Confronta BEAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.29 | 54.10M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
282.61 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
59.18 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
59.31 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
101.28 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.67 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology - TipRanks
IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch - Yahoo Finance
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 - Business Wire
BEAT Stock: A Comprehensive Analysis and Forecast - investchronicle.com
HeartBeam Inc. Pioneers Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring - citybuzz -
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG - citybuzz -
HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG - financial-news.co.uk
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results - citybuzz -
Here's Why HeartBeam (NASDAQ:BEAT) Must Use Its Cash Wisely - Yahoo Finance
HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing
Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India
HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com
HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus
HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer
HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa
Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria
HeartBeam, Inc. SEC 10-Q Report - TradingView
HeartBeam Reports First Quarter 2025 Results - Business Wire
The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail
HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance
Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com
Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com
HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing
HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com
HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -
HeartBeam (NASDAQ: BEAT) Appoints CEO Robert Eno To Board Of Directors - Barchart.com
HeartBeam (BEAT) Welcomes CEO Robert Eno to Its Board of Directo - GuruFocus
HeartBeam Appoints CEO Robert Eno to Board - TipRanks
HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India
HeartBeam expands board, appoints CEO to director role - Investing.com Australia
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph
HeartBeam, Inc. Appoints Robert Eno to Board of Directors - marketscreener.com
HeartBeam CEO Robert Eno joins company’s board as commercialization nears - Medical Economics
HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com
HeartBeam (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13 - Barchart.com
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph
HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace
Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Heartbeam Inc Azioni (BEAT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cruickshank Tim | CFO |
Feb 14 '25 |
Buy |
1.70 |
17,647 |
30,000 |
17,647 |
| de Urioste George | Director |
Sep 06 '24 |
Sale |
2.34 |
1,674 |
3,917 |
57,146 |
| de Urioste George | Director |
Aug 30 '24 |
Sale |
2.31 |
5,500 |
12,705 |
58,820 |
| de Urioste George | Director |
Aug 27 '24 |
Sale |
2.26 |
2,194 |
4,958 |
64,320 |
| de Urioste George | Director |
Aug 23 '24 |
Sale |
2.30 |
2,500 |
5,750 |
66,814 |
| de Urioste George | Director |
Aug 26 '24 |
Sale |
2.38 |
300 |
714 |
66,514 |
1.70%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):